Ontario likely to give mixed COVID vaccine doses due to shortage of AstraZeneca: minister | National Post
Quebec has also said that it plans to mix vaccines due to supply shortages, substituting the Pfizer-BioNTech vaccine for the Moderna vaccines
Author of the article:
Publishing date:
May 10, 2021
•
1 day ago
•
1 minute read
•
One health expert says some Canadians who have already received the Oxford-AstraZeneca shot may be comforted to know they have the option of a different dose. Photo by Dado Ruvic/Illustration/Reuters
TORONTO — Ontario will likely mix and match COVID-19 vaccine doses in light of uncertain future supply of all the shots approved for use in Canada.
Health Minister Christine Elliott says it’s likely that recipients of the Oxford-AstraZeneca vaccine may receive a different shot for their second dose.
The province is waiting for the results from a U.K. study on mixing different vaccines and on advice from a federal immunization panel.
Quebec has also said that it plans to mix vaccines due to supply shortages, substituting the Pfizer-BioNTech vaccine for the Moderna vaccines in order to quickly give booster shots to long-term care residents.
It’s unclear when more Oxford-AstraZeneca shots will arrive but Ontario is expecting millions of Pfizer-BioNTech shots in the coming weeks.
Biologist and science communicator Samantha Yammine says some Canadians who have already received the Oxford-AstraZeneca shot may be comforted to know they have the option of a different dose.
Advertisement
This advertisement has not loaded yet, but your article continues below.
Mixing COVID-19 vaccines could be making the best 'of a bad situation'
Should we mix-and-match doses from different COVID-19 vaccines? Experts say maybe
She says the pandemic has given rise to an “infodemic,” with a flood of advice about areas like the low risk of blood clots from viral-vector shots compared with mRNA vaccines.
Even with more mRNA vaccines on the way, Yammine says Canada should be careful about dismissing shots like Oxford-AstraZeneca’s because they are important to ending the global pandemic.
The National Advisory Committee on Immunization sparked controversy when it recommended that Canadians who aren’t at high risk from COVID-19 may want to wait until a dose of Pfizer-BioNtech or Moderna is available, calling them the “preferred” vaccines.
The comments were met with harsh criticism from public health officials and members of the public, and the chair of the committee said last week that the recommendation was not “retrospective” and that those who got the AstraZeneca vaccine did the right thing to protect themselves and their families.
NP Posted
Sign up to receive the daily top stories from the National Post, a division of Postmedia Network Inc.
By clicking on the sign up button you consent to receive the above newsletter from Postmedia Network Inc. You may unsubscribe any time by clicking on the unsubscribe link at the bottom of our emails. Postmedia Network Inc. | 365 Bloor Street East, Toronto, Ontario, M4W 3L4 | 416-383-2300We encountered an issue signing you up. Please try again